Grifols, S.A.

$8.85+0.00%(+$0.00)
TickerSpark Score
76/100
Solid
87
Valuation
70
Profitability
70
Growth
72
Health
80
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GIFOF research report →

52-Week Range100% of range
Low $8.20
Current $8.85
High $8.85

Companywww.grifols.com

Grifols, S. A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives.

CEO
Jose Ignacio Abia Buenache
IPO
2013
Employees
23,833
HQ
Barcelona, ES

Price Chart

+7.27% · this period
$8.85$8.52$8.20May 19Nov 17May 19

Valuation

Market Cap
$8.70B
P/E
15.68
P/S
0.88
P/B
1.19
EV/EBITDA
10.80
Div Yield
1.57%

Profitability

Gross Margin
37.68%
Op Margin
16.89%
Net Margin
5.58%
ROE
7.88%
ROIC
5.49%

Growth & Income

Revenue
$7.52B · 4.28%
Net Income
$401.74M · 156.02%
EPS
$0.59 · 168.18%
Op Income
$1.25B
FCF YoY
47.27%

Performance & Tape

52W High
$8.85
52W Low
$8.20
50D MA
$8.76
200D MA
$8.81
Beta
1.17
Avg Volume
100

Get TickerSpark's AI analysis on GIFOF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our GIFOF Coverage

We haven't published any research on GIFOF yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate GIFOF Report →

Similar Companies